Clinical Trial Update: Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of two oxybutynin delivery methods—OROS oxybutynin and transdermal Oxybutynin (TTS)—in middle-aged and e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• OROS Oybutynin (oxybutynin)
• TTS Oxybutynin (oxybutynin)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED